Aptevo Therapeutics APVO
NASDAQ APVO
$1.80 +0.04 (+2.27%)
As of: Oct 2, 2026 · 2:24 PM EDT

Aptevo Therapeutics (APVO) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Aptevo Therapeutics' Depreciation & Amortization (CF) was $32,000 in Q2 2026, down 34.7% from $49,000 a year earlier and down 8.6% from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aptevo Therapeutics' Depreciation & Amortization (CF) was $197,000 through Jun 30, 2026, down 25.7% year-over-year; for FY2025, it came in at $240,000, down 31.8% from FY2024.

  • Depreciation & Amortization (CF) has now declined for nine consecutive years, with a five-year compound annual growth rate of -29.8% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $352,000 in FY2024 (-37.9%), $567,000 in FY2023 (-37.1%), $901,000 in FY2022 (-21.2%) and $1.14 million in FY2021 (-18.6%).
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) in data going back to Q4 2015.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in 1 of the last eight quarters, with an average decline of 33.0%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2025 (growth of 14.1%); the worst was Q2 2025 (a decline of 46.2%).
  • Per Business Quant data, APVO's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $35,000 (Q1 2026), $81,000 (Q4 2025) and $49,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn - 32,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32,000.00
Mar 31, 2026 35,000.00
Dec 31, 2025 81,000.00
Sep 30, 2025 49,000.00
Jun 30, 2025 49,000.00
Mar 31, 2025 61,000.00
Dec 31, 2024 71,000.00
Sep 30, 2024 84,000.00
Jun 30, 2024 91,000.00
Mar 31, 2024 106,000.00
Dec 31, 2023 116,000.00
Sep 30, 2023 123,000.00
Jun 30, 2023 150,000.00
Mar 31, 2023 178,000.00
Dec 31, 2022 161,000.00
Sep 30, 2022 222,000.00
Jun 30, 2022 276,000.00
Mar 31, 2022 242,000.00
Dec 31, 2021 256,000.00
Sep 30, 2021 295,000.00
API Access

Aptevo Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=APVO&period=max&api_key=YOUR_API_KEY